Sign In
Buy GTLL
$0.0001
+0 (+0%)
At Close: Aug 05, 2026
CI Global Asset Management Announces Special Reinvested Distribution for CI ICBCUBS S&P China 500 Index ETF (CHNA.B)
07:00am, Thursday, 28'th May 2026
TORONTO--(BUSINESS WIRE)---- $CHNA.B #CIFinancial--CI Global Asset Management announces a special reinvested distribution for CI ICBCUBS S&P China 500 Index ETF (TSX: CHNA.B).
Enanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
07:00am, Thursday, 28'th May 2026
WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
07:00am, Thursday, 28'th May 2026
BOSTON, May 28, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana”), a biotechnology company developing its lead candidate, intranasal foralumab, a fully human, anti-C
GigaCloud Technology Inc to Present at Baird's 2026 Global Consumer, Technology & Services Conference
07:00am, Thursday, 28'th May 2026
EL MONTE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
07:00am, Thursday, 28'th May 2026
CORAL GABLES, Fla., May 28, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapie
NovaBridge to Present at the 2026 Jefferies Global Healthcare Conference
07:00am, Thursday, 28'th May 2026
ROCKVILLE, Md., May 28, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative
Nektar Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference in New York
06:15pm, Wednesday, 27'th May 2026
SAN FRANCISCO, May 27, 2026 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the 2026 Jefferies Global Healthcare Co
Rocket Doctor AI Announces Global Company Town Hall to Showcase 2025 Milestones; Q1 2026 Milestones and Strategic Vision
05:35pm, Wednesday, 27'th May 2026
Vancouver, BC, May 27, 2026 (GLOBE NEWSWIRE) -- Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI” or the “Company”), a physician-built, AI-powered healthcar
DiaMedica Therapeutics to Present at the Jefferies Global Healthcare Conference 2026
04:30pm, Wednesday, 27'th May 2026
MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction a
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
04:30pm, Wednesday, 27'th May 2026
SAN DIEGO, May 27, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today announced that chief executive officer Kristin Yarema, Ph.D., will present at the
Announcement is made after successful proof-of-concept trial in a preclinical model of intravenous delivery of large molecule tracers across the blood-brain barrier guided by prototype systems, includ
Jason Winkler, Executive Vice President and CFO, Motorola Solutions, to Participate in the 2026 BofA Global Technology Conference
04:15pm, Wednesday, 27'th May 2026
CHICAGO--(BUSINESS WIRE)--Motorola Solutions (NYSE: MSI), a global leader in mission-critical safety and security solutions, today announced that Jason Winkler, Executive Vice President and CFO, will
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
04:05pm, Wednesday, 27'th May 2026
BERKELEY, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz,
Digital Realty Publishes 2025 Impact Report, Highlighting Sustainability Progress
04:05pm, Wednesday, 27'th May 2026
Achieves 93% Global Renewable Energy Coverage in 2025, up 18% Over Prior Year Achieves 93% Global Renewable Energy Coverage in 2025, up 18% Over Prior Year
Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
04:05pm, Wednesday, 27'th May 2026
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced plans
